TCL Archive Also Von Eschenbach role in industry program raises new concerns of conflict of interest. November 23, 2005
TCL Archive FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer April 29, 1988
TCL Archive Zinder Report Asks VCP To Switch Most Research To Grants, Spread Work Among More Scientists, Change Review Groups March 22, 1974
TCL Archive FDA’s Commitment To Cancer No Different Than Other Diseases, Kessler Tells Advocate August 14, 1992
TCL Archive Scientists Lobby For Funding Increase. DuBois To Leave Vanderbilt For M.D. Anderson. January 12, 2007